North America Stem Cell Therapy Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)

No. of Pages: 133
Report Code: BMIRE00028486
Category: Life Sciences
North America Stem Cell Therapy Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. North America Stem Cell Therapy Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. North America Stem Cell Therapy Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. North America Stem Cell Therapy Market Regional Analysis

6.2 North America Stem Cell Therapy Market Revenue 2020-2028 (US$ Million)
6.3 North America Stem Cell Therapy Market Forecast Analysis

7. North America Stem Cell Therapy Market Analysis – by Type

7.1 Adult Stem Cell Therapy
  • 7.1.1 Overview
  • 7.1.2 Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Embryonic Stem Cell Therapy
  • 7.2.1 Overview
  • 7.2.2 Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Induced Pluripotent Stem Cell Therapy
  • 7.3.1 Overview
  • 7.3.2 Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Other Stem Cell Therapy
  • 7.4.1 Overview
  • 7.4.2 Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. North America Stem Cell Therapy Market Analysis – by Treatment

8.1 Allogeneic
  • 8.1.1 Overview
  • 8.1.2 Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Autologous
  • 8.2.1 Overview
  • 8.2.2 Autologous: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. North America Stem Cell Therapy Market Analysis – by Application

9.1 Musculoskeletal
  • 9.1.1 Overview
  • 9.1.2 Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Dermatology
  • 9.2.1 Overview
  • 9.2.2 Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Cardiology
  • 9.3.1 Overview
  • 9.3.2 Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Drug Discovery & Development
  • 9.4.1 Overview
  • 9.4.2 Drug Discovery & Development: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.5 Other Applications
  • 9.5.1 Overview
  • 9.5.2 Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. North America Stem Cell Therapy Market Analysis – by End User

10.1 Hospitals & Specialty Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Academic & Research Institutes
  • 10.2.1 Overview
  • 10.2.2 Academic & Research Institutes : North America Stem Cell Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. North America Stem Cell Therapy Market – North America Analysis

11.1 Overview

11.2 North America
  • 11.2.1 North America Stem Cell Therapy Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 11.2.1.1 North America Stem Cell Therapy Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 US: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 US: North America Stem Cell Therapy Market Breakdown, by Type
    • 11.2.1.1.2 US: North America Stem Cell Therapy Market Breakdown, by Treatment
    • 11.2.1.1.3 US: North America Stem Cell Therapy Market Breakdown, by Application
    • 11.2.1.1.4 US: North America Stem Cell Therapy Market Breakdown, by End User
  • 11.2.1.2 Canada: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Canada: North America Stem Cell Therapy Market Breakdown, by Type
    • 11.2.1.2.2 Canada: North America Stem Cell Therapy Market Breakdown, by Treatment
    • 11.2.1.2.3 Canada: North America Stem Cell Therapy Market Breakdown, by Application
    • 11.2.1.2.4 Canada: North America Stem Cell Therapy Market Breakdown, by End User
  • 11.2.1.3 Mexico : North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Mexico : North America Stem Cell Therapy Market Breakdown, by Type
    • 11.2.1.3.2 Mexico : North America Stem Cell Therapy Market Breakdown, by Treatment
    • 11.2.1.3.3 Mexico : North America Stem Cell Therapy Market Breakdown, by Application
    • 11.2.1.3.4 Mexico : North America Stem Cell Therapy Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 MEDIPOST
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 RichSource
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 BioTime, Inc.
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Mesoblast Limited
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 U.S. Stem Cell, Inc.
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 TiGenix NV
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 AlloSource
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 NuVasive Inc
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - North America Stem Cell Therapy Market

  • MEDIPOST
  • RichSource
  • BioTime, Inc.
  • Mesoblast Limited
  • U.S. Stem Cell, Inc.
  • TiGenix NV
  • AlloSource
  • NuVasive Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)